ABSTRACT Cholesterol is essential for neuronal development and brain function. Previously we reported that in ovo administration of betaine modulates hepatic cholesterol metabolism in the chicken, yet it remains unknown whether maternal betaine affects the cholesterol content and the expression of cholesterol metabolic genes in chicken hypothalamus. In this study, eggs were injected with saline or betaine at 2.5 mg/egg, and the hatchlings were raised under the same condition until 64 d of age. Maternal betaine significantly (P = 0.05) increased the body weight and suppressed aggressive behavior of 64-day-old cockerels, in association with significantly (P < 0.05) up-regulated expression of 5-HTR1A receptor in the hypothalamus. Concurrently, betaine in ovo significantly increased (P < 0.05) the hypothalamic content of total cholesterol and cholesterol ester, which coincided with significantly up-regulated (P < 0.05) hypothalamic expression of cholesterol biosynthetic genes, such as sterol-regulatory element binding protein 2 and 3-hydroxy-3-methylglutaryl-CoA reductase as well as acetyl-CoA cholesterol acyltransferase 1, which converts free cholesterol to cholesterol ester for storage. In contrast, low density lipoprotein receptor, which mediates the cholesterol uptake, was significantly down-regulated (P < 0.05). In ovo betaine administration significantly enhanced the expression of betaine-homocysteine methyltransferase and DNA methyltransferase 1 (P < 0.05), which was associated with alterations of CpG methylation on the promoter of modified cholesterol metabolic genes. These results indicate that maternal betaine modulates hypothalamic cholesterol metabolism in cockerels through modifying DNA methylation on the promoter of cholesterol metabolic genes.
INTRODUCTION
Brain is the most cholesterol-rich organ, which contains more than 20% of the total cholesterol present in the whole body in both mammals (Dietschy and Turley, 2004) and chicken (Connor et al., 1969) . Cholesterol is important for neuronal development and brain function, especially during embryonic and early postnatal stages (Zhang and Liu, 2015) . Cholesterol not only is an essential structural component for cellular membrane and myelin, but it is also required for synapse and dendrite formation (Fester et al., 2009) , as well as axonal guidance (de Chaves et al., 1997) . Cholesterol can influence cell function through its biologically active oxidized product oxysterol (Radhakrishnan et al., 2007) . Cholesterol depletion in neurons impairs synaptic vesicle exocytosis, neuronal activity and neurotransmission, leading to dendritic spine and synapse degeneration (Linetti et al., 2010) . Defects in cholesterol metabolism lead to structural and functional brain diseases such as Niemann-Pick C disease, Huntington's disease, Alzheimer's disease, and Parkinson's disease (Wang et al., 2011) . Knockdown of sterol regulatory element binding protein 2 (SREBP2), the key cholesterol biosynthesis regulator, disrupts synapse formation in cultured neurons in vitro and affects feeding and weight gain in a mouse model lacking SREBP-2 in the hypothalamus (Suzuki et al., 2010) .
Hypothalamus plays an important role in the regulation of autonomic functions including growth, energy homeostasis and stress response. In vitro study demonstrated that cholesterol depletion in hypothalamic neurons induces insulin and growth factor resistance that may contribute to increased risk of neurodegenerative diseases (Naseem and Heald, 1987) .
Low serum cholesterol concentrations are linked to violent or antisocial behavior in psychiatric and criminal populations, whereas high-fat, high-cholesterol diet is associated with less aggression behavior in monkeys (Kaplan et al., 1991) . A link between low cholesterol and altered central 5-hydroxytryptamine (5-HT) activity was proposed (Buydens-Branchey et al., 2000) , and serotonin 1A receptor (5-HTR1A) appears to be a target of cholesterol action (Pucadyil and Chattopadhyay, 2005; Chattopadhyay and Paila, 2007) . Serotonin system is involved in the regulation of aggression behavior in birds (Dennis et al., 2008 ), yet no data are available linking hypothalamic cholesterol content and 5-HTR1A expression with change of adverse effect of aggressive behavior in the chicken. It has been shown that aggressive behavior such as pecking may lead to plumage damage in the chicken (Hartcher et al., 2015) .
Cholesterol in the brain is almost exclusively derived from de novo synthesis, as there is no evidence for the transfer of cholesterol from the blood to the brain (Dietschy and Turley, 2004) Brain cholesterol accumulates mainly between the perinatal period and adolescence when neurons are forming their myelin. Cholesterol homeostasis in the brain is stringently regulated through a balance between biosynthesis, storage, and excretion. Sterol regulatory element-binding protein 2 (SREBP2) is a primary transcriptional factor for the activation of cholesterol biosynthesis genes, including the rate-limiting enzyme 3-hydroxy-3-methyl-glutarylCoA reductase (HMGCR) (Sharpe and Brown, 2013) . When cells are loaded with excess unesterified free cholesterol, acetyl-CoA cholesterol acyltransferase 1 (ACAT1) converts free cholesterol to cholesterol ester for storage in the endoplasmic reticulum (Dietschy and Turley, 2004) . Cytochrome P46A1 (CYP46A1) oxidizes cholesterol to 24S-hydroxycholesterol (Goyal et al., 2014) , that can cross brain blood barrier much faster than cholesterol itself for excretion (Lange et al., 1995; Meaney et al., 2002) . Moreover, low density lipoprotein receptor (LDLR) mediates the cholesterol influx, whereas ATP-binding cassette (ABC) transporters, namely ABCA1, ABCG1, and ABCG4, mediate cellular sterol efflux at the plasma membrane (Gelissen et al., 2006; Vaughan and Oram, 2006) . Studies on brain cholesterol homeostasis are restricted to mammalian species, and relevant information in avian species is missing.
Betaine, derived from either choline oxidation or dietary intake, is critical for embryonic and fetal development (Lever and Slow, 2010) . Betaine functions as a methyl donor to convert homocysteine to methionine in a reaction catalyzed by betaine homocysteine methyltransferase (BHMT) (Villamor et al., 2012) . Methionine is converted to S-adenosylmethionine (SAM), the most important methyl donor, for different methylation reactions catalyzed by various methyltransferases (Mudd, 2011) . Dietary supplementation of betaine in rats can prevent obesogenic diet-induced hepatic steatosis and fatty liver (Cordero et al., 2013) . Previously, we reported that maternal betaine increases hepatic cholesterol accumulation in neonatal piglets (Cai et al., 2014) and newly hatched chickens through epigenetic mechanisms including DNA and histone methylations (Hu et al., 2015) . However, it remains unknown whether maternal betaine may affect hypothalamic cholesterol accumulation in chicken offspring.
Therefore, the present study was aimed to investigate the effect of in ovo betaine administration on cholesterol content and the expression of cholesterol metabolic genes in chicken hypothalamus; and to link these changes with alterations of growth performance and aggressive behavior. Furthermore, betaine metabolism and methyl transfer genes, together with DNA methylation status on gene promoters, are determined to reveal the possible mechanisms.
MATERIALS AND METHODS

Ethics Statement
The Animal Ethics Committee of Nanjing Agricultural University approved the experimental protocol, with the project number 2012CB124703. 
Animals and Treatment
One hundred and forty fertilized eggs (42.1 ± 0.11 g) laid by Rugao yellow breeder hens were obtained from Poultry Institute of Yangzhou, Jiangsu, China. A chicken egg was reported to contain about 0.3 mg betaine (Zeisel et al., 2003) . Considering that exogenously administered substances usually have much lower bioavailability, we tested the dose-dependent effects using low dose (0.25 mg/egg) and high dose (2.5 mg/egg). Because no significant effects were observed in low-dose treatment, we used high dose (2.5 mg/egg) in the present study as in a previous publication (Hu et al., 2015) . Before incubation, eggs were randomly divided into control and betaine groups (70 in each group), and were injected with 100 μL of saline or betaine (2.5 mg per egg; B2629, SigmaAldrich, St. Louis, MO), respectively, as previously described (Haussmann et al., 2012) . In brief, eggs were injected by advancing a Hamilton syringe into a hole in the middle of the long axis until the yolk membrane was penetrated (approximately 20 mm below the surface). Chicks were hatched inside the incubator and were left to dry completely (up to 12 h) before they were removed. No obvious differences in hatchability or hatching time were observed between 2 groups. The incubator was set according to our previous publication (Ahmed et al., 2014) . The newly hatched chicks were individually weighed, wing labeled, and transferred into battery cages with continuous illumination. The temperature was controlled in the range of 35 to 37
• C during wk 1, and reduced approximately 3
• C per wk until 21
• C. The stock density was about 30 kg/m 2 . The relative humidity was maintained at 40 to 60%, and the lighting, ventilation, as well as the feeding and management procedures complied with the Feeding Management Regulations of local breeds of Rugao Chickens. Chickens were weighed every week. On 61 d of age, 8 male chickens of the average body weight in each group were selected for behavior test and sacrificed on 64 d of age for sampling.
Blood samples were taken from the jugular vein into heparinized tubes and centrifuged at 3,000 × g, 4
• C for 10 min to prepare plasma. Hypothalamuses were dissected according to a previous publication (Yuan et al., 2009 ) and rapidly frozen in liquid nitrogen, then stored at -70
• C for further analysis.
Behavior Test
The behavior test was performed on D61 as previously described (Kitaysky et al., 2003) . Briefly, 8 male chickens from each group were placed in an experimental arena (similar in size and structure to the nests where the chickens were raised) established in a room familiar to the chickens. The room was visually and acoustically isolated from the aviary of other chickens. Aggression was defined as a chicken pecking, grabbing, and twisting the head or the nape of other chickens. A person who was blind to the experimental design performed all the behavioral observations and analyses (Ahmed et al., 2014) .
Total Cholesterol, Cholesterol Ester, and Free Cholesterol Content
Total cholesterol (Tch, E1015) and free cholesterol (E1016) in the hypothalamus were measured by using respective commercial cholesterol assay kits purchased from Applygen Technologies (Beijing, China), which were previously validated for detecting cholesterol contents in chicken serum and liver (Hu et al., 2015) . Cholesterol ester content was calculated by subtracting the free cholesterol content from the Tch content. Briefly, approximately 15 mg of ground hypothalamic sample was homogenized in 0.3 mL ice-cold buffer RIPA (18 mmol/L Tris, pH 7.5, 300 mmol/L mannitol, 50 mmol/L EDTA, and 0.1 mmol/L PMSF) with a Polytron homogenizer (PT1200E, Brinkman Instruments, Littau, Switzerland), and used in the assay following the manufacturer's instructions.
Total RNA Isolation and Quantitative Real-Time PCR
Total RNA was isolated from 20 mg ground hypothalamic samples with TRIzol reagent (Invitrogen, Carlsbad, CA). Two micrograms of total RNA were treated with RNase-free DNase and reverse-transcribed to cDNA using a random hexamer primer (Promega, USA). Two microliters of diluted cDNA (1:25, vol/vol) were used for real-time PCR that was performed with an Mx3000P Real-Time PCR System (Stratagene, San Diego, CA). The technical variations were normalized using β-actin as an internal control. Primers used for real-time PCR (Table 1) were synthesized by Generay Biotech (Shanghai, China). Data were analyzed using the method of 2 -CT (Livak and Schmittgen, 2001 ).
Protein Extraction and Western Blotting
Total protein was extracted from 20 mg ground hypothalamus sample as previously described (Duan et al., 2014) . Protein concentrations were determined using Pierce BCA Protein Assay kit (Rockford, IL) according to the manufacturer's instructions. 40 μg of protein was used for electrophoresis on a 10% or 7.5% SDS-PAGE gel. , MAT2B (15952-1-AP, diluted 1:500; Proteintech), DNMT1 (24206-1-AP, diluted 1:1000; Proteintech), and DNMT3a (bs6587, Bioworld Technology USA, diluted 1:500) was carried out according to the recommended protocols provided by the manufacturers. The β-actin (AP0060, diluted 1:10,000; Bioworld Technology) was used as loading control in the Western blot analysis. Images were captured by Versa Doc 4000MP system (Bio-Rad, Hercules, CA) and the band density was analyzed with Quantity One software (BioRad). The antibodies used in the present study were raised against human, mouse, or rat antigens, but have cross-reactivity with avian proteins. We selected the antibodies based on previous publications in chickens, the recommendations to use in chickens in the product data sheets, or the homology of the amino acid sequence of the peptides used as antigens to produce antibodies.
Methylated DNA Immune Precipitation (MeDIP) Analysis
High-quality genomic DNA was isolated from hypothalamic tissues and sonicated to fragments of approximately 500 bp in size. Two micrograms of fragmented DNA were heat-denatured to produce singlestranded DNA, and a portion of the denatured DNA was stored as input DNA. A mouse monoclonal antibody against 5-methyl cytosine (ab10805, Abcam, Cambridge, UK) was used to immunoprecipitate the methylated DNA fragments. The immune complexes were captured with protein G agarose beads pretreated with denatured salmon sperm DNA and BSA (P2009, Beyotime Institute of Biotechnology, China). The beads bound to immune complexes were washed to eliminate non-specific binding and suspended in 250-μL digestion buffer containing proteinase K. Finally, the MeDIP DNA was purified. A small aliquot of MeDIP DNA and control input DNA was used to amplify the proximal promoter sequence of chickens SREBP2, HMGCR, ACAT1, CYP46A1, LDLR and ABCA1 genes by realtime PCR with specific primers listed in Table 1 . Data was normalized against the input and presented as the fold change relative to the average value of the control group.
Statistical Analysis
The results are presented as means ± SEM. Comparisons were performed using independent-samples t-test with SPSS 18.0 for Windows. The differences were considered statistically significant when P < 0.05. Values are means ± SEM. N = 8. BW, body weight; Tch, total cholesterol; free cho, free cholesterol; cho ester, cholesterol ester.
RESULTS
Body Weight, Aggressive Behavior, and Hypothalamus Content of Cholesterol
The body weight of betaine-treated chickens tended to be higher (P = 0.05) at 64 d of age (Table 2 ). The frequency of aggressive behaviors ( Figure 1A ) did not change, yet the duration of pecking (P < 0.05) was significantly decreased in betaine-treated chickens ( Figure 1B) , as was the total time of aggressive behavior in 60 min ( Figure 1C ). In ovo injection of betaine significantly suppressed (P < 0.05) the aggressive behavior and increased (P = 0.05) the body weight of 64-day-old cockerels ( Table 2 ). The frequency of aggressive behaviors ( Figure 1A ) did not change, yet the duration of grabbing and twisting (P < 0.05) was significantly decreased in betaine-treated chickens ( Figure 1B) . In ovo injection of betaine significantly increased the total cholesterol (P < 0.01) and cholesterol ester (P < 0.01) contents in the hypothalamus. However, the free cholesterol in hypothalamus (P = 0.28) did not differ between betaine and control groups (Table 2) .
Hypothalamic Expression of Serotonergic Genes
Betaine in ovo significantly up regulated the hypothalamic expression of 5-HTR1A mRNA (P < 0.05), while MAO-A mRNA tended to be down-regulated (P = 0.07). No significant differences were detected for the mRNA abundance of 5-HTR1B or MAO-B in the hypothalamus between betaine and control groups ( Figure 1D ).
Hypothalamic Expression of Cholesterol Metabolic Genes
In ovo betaine injection significantly (P < 0.05) augmented the hypothalamic expression of SREBP2 and HMGCR at both mRNA ( Figure 2A ) and protein ( Figure 2B ) levels. The same was true also for ACAT1 that converts free cholesterol to cholesterol ester for storage (P < 0.05). In contrast, both mRNA and protein levels of LDLR was significantly down-regulated (P < 0.05) in betaine group compared to control group (Figure 2A and 2B ). ABCA1 and CYP46A1, which mediate sterol efflux and turnover, were both up-regulated (P < 0.05) at mRNA level (Figure 2A ). The protein content of ABCA1 and CYP46A1 was not detected due to lack of specific antibodies.
Hypothalamic Expression of Betaine Metabolism and Methyl Transfer Genes
Betaine significantly increased BHMT and DNMT1 expression at both mRNA (P< 0.05, Figure 3A ) and protein (P < 0.05, Figure 3B ) levels. No significant alterations were detected for other genes involved in betaine metabolism and methyl transfer, which include DNMT3A ( Figure 2B ).
DNA Methylation Status on The Promoter of Modified Cholesterol Metabolic Genes
The detected regions of chicken SREBP2, HMGCR, CYP46A1, ABCA1, ACAT1, and LDLR gene promoters contain different numbers of CpG sites ( Figure 4A ). The methylation status of these regions was determined with MeDIP analysis ( Figure 4B) . Promoters of HMGCR, ABCA1 and ACAT1 genes were significantly hypomethylated (P < 0.05) in betaine-treated group, which coincided with higher mRNA abundances detected for these three genes. Conversely, LDLR gene promoter tended to be hypermethylated (P = 0.09), which correlated with its down-regulation at the level of mRNA.
DISCUSSION
In this pilot study, we provide the first evidence that, higher cholesterol content in the hypothalamus is associated with increased body weight and suppressed aggressive behavior in the chicken prenatally treated with betaine. A number of studies in mammalian species, including humans, indicate a link between cholesterol content and aggressive behavior. Epidemiologic data suggest that reduced cholesterol level is related to increased suicide and violence-related death (Kaplan et al., 1997) , as well as the expression of aggressive and impulsive behaviors, antisocial personality disorder and criminal violence in humans (Golomb et al., 2000) . The studies in primates also demonstrated an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys (Fontenot et al., 1996) . Animals fed a low-cholesterol diet were found to be more aggressive and had lower cerebrospinal fluid concentration of 5-hydroxyindole acetic acid, the main metabolite of serotonin (Kaplan et al., 1994) . Our observation in the chicken agrees with those reported in mammals in terms of the aggressive behavior. The higher body weight observed in betaine-treated chickens may attribute to the direct growth-promoting effect of betaine or the consequence of up-regulated hypothalamic 5-HTR1A expression and suppressed aggressive behavior. Cholesterol metabolism in the brain is isolated from the peripheral circulation by the blood brain barrier (BBB), which prevents lipoprotein exchange and is thus impermeable to cholesterol (Pfrieger and Ungerer, 2011) . In the brain, cholesterol is synthesized de novo from acetyl CoA by different cells. Interestingly, the predominant cholesterol synthesis switches from neurons during embryogenesis to oligodendrocytes during postnatal myelination and to mainly astrocytes in the adult (Saher and Stumpf, 2015) . Cholesterol homeostasis in adult brain relies on the cooperation between astrocytes and neurons, in which astrocytes are major producers while neurons are consumers with unique means for cholesterol uptake, storage, conversion, and secretion (Pfrieger and Ungerer, 2011) .
In the present study, it was not possible to determine brain cholesterol metabolism in a cell-specific manner. We could only detect the overall expression of cholesterol metabolic genes in the chicken hypothalamus. Increased cholesterol content in the hypothalamus of betaine-treated chickens was associated with augmented expression of SREBP2 and HMGCR, which indicates augmented cholesterol biosynthesis in hypothalamus. Also, the up-regulation of ACAT1 may implicate enhanced esterification from free cholesterol to cholesterol ester, thus increasing the storage of cholesterol in lipid droplets as a reserve pool (Tessema and Belinsky, 2008; Seet et al., 2011) . LDLR is one of the main receptors for the uptake of apoE-containing lipoprotein particles in the brain, which is more highly expressed in neurons than in glial cells (Rebeck et al., 1993) . We found that LDLR is significantly down regulated in betaine-treated chickens with higher cholesterol content in the hypothalamus. This may be caused by a negative feedback regulation of cholesterol uptake in response to higher cholesterol content (Zhang et al., 2012) . Moreover, the up-regulated mRNA expression of ABCA1 and CYP46A1 may indicate increased sterol efflux and turnover in response to higher cholesterol content, but we cannot draw the conclusion simply based on mRNA levels because the steady-state levels of mRNA do not always reflect the contents of proteins that exert biological functions.
Betaine in ovo administration modified the expression of cholesterol metabolic genes in chicken hypothalamus, which is in line with our previous report that maternal betaine supplementation increases hepatic cholesterol accumulation in neonatal piglets through modification of cholesterol metabolic genes (Cai et al., 2014) . Similar to the findings in piglet (Li et al., 2015) , in ovo betaine administration also modulated the expression of one-carbon metabolic and methyl transfer genes in the chicken. BHMT, the only known enzyme that uses betaine as substrate to convert homocysteine to methionine (Pajares and Perez-Sala, 2006) , was upregulated at both mRNA and protein levels. Moreover, DNMT1, the major DNA methyltransferase responsible for the maintenance of CpG methylation status, was also significantly activated at both mRNA and protein levels. Similar activation of DNMT1 was reported in the hippocampus of neonatal piglets derived from sows fed betaine-supplemented diet during gestation (Li, Sun, Li, Cai, Sui, Jia, Song and Zhao, 2015) . DNMT1 over-expression generally leads to increased global DNA methylation (Biniszkiewicz et al., 2002) . However, decreased level of CpG methylation was detected in the promoter regions of HMGCR, ABCA1 and ACAT1 genes in the hypothalamus of betaine-treated chickens, in association with increased level of mRNA for these genes. In contrast, hypermethylation of LDLR gene promoter coincided with suppression of LDLR expression in the hypothalamus of betaine-treated chickens. These findings are accordant with previous reports that a modest decrease in ACAT1 promoter methylation flowing homocysteine treatment was contemporaneous with an increase in ACAT1 expression and cholesteryl ester content (Liang et al., 2013) , and the hepatic expression of ACAT1 in hyperhomocysteinemic mice was reduced in the context of elevated DNA methylation (Devlin et al., 2010) . It is surprising that DNMT1, the maintenance DNA methyltransferase during DNA replication, was up-regulated at both mRNA and protein levels, whereas DNMT3A and DNMT3B, which are responsible for de novo DNA methylation, were either not affected by betaine in ovo injection or not detected in the chicken hypothalamus in the present study. It is presumed that betaine injected in ovo modified early embryonic development when most cells are in proliferation stage when DNA replication takes place. Nevertheless, it remains a mystery how DNA methylation on the promoters of different genes is differently regulated in the context of the present experiment.
CONCLUSIONS
Taken together, here we show in a pilot study that in ovo injection of betaine may modulate growth and aggressive behavior in the chicken. These phenotypic alterations were associated with modified expression of serotonergic and cholesterol homeostasis in the hypothalamus of cockerels. Modified DNA methylation on the promoter of cholesterol metabolic genes may contribute, at least in part, to the modulation of cholesterol metabolic genes caused by prenatal betaine exposure. These results may provide new evidence for the fetal programming effects of betaine on the cholesterol homeostasis, as well as the brain development and function in the chicken. 
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